PURPOSE: To evaluate and quantify the association between consumption of specific food
groups/macronutrients and concentrations of serum insulin-like growth factor 1 (IGF-1) and …

PURPOSE: Insulin-like growth factor (IGF-1) and its major binding protein (IGF-BP3) have
recently been implicated in the pathogenesis of several malignancies. However, …

Parkinson’s disease (PD) is the second more common neurodegenerative disease with
increasing incidence worldwide associated to the population ageing. Despite increasing …

Background There is a need for biomarkers to support an accurate diagnosis of Parkinson’s
disease (PD). Cerebrospinal fluid (CSF) has been a successful biofluid for finding …

Background Prior statin treatment and high admission cholesterol have been associated with
favorable outcome after ischemic stroke (IS), a paradox not completely explained. The aim …

Background The interplay between glycemic control and Parkinson's disease (PD) has long
been recognized but not fully understood. Objectives To investigate the association of …

Objective Decreased amyloid beta (Aβ) 42 together with increased tau and phospho‐tau in
cerebrospinal fluid (CSF) is indicative of Alzheimer’s disease (AD). However, the molecular …

Background Alteration in glycosphingolipids (GSLs) in Parkinson's disease (PD) still needs
to be determined. Objectives We evaluated if PD subjects show abnormal GSLs levels …

Background: Visual and oculomotor problems are very common in Parkinson’s disease (PD)
and by using eye-tracking such problems could be characterized in more detail. However, …

Differential diagnosis of parkinsonism early upon symptom onset is often challenging for
clinicians and stressful for patients. Several neuroimaging methods have been previously …